The effect of intravitreal bevacizumab injection before Ahmed valve implantation in patients with neovascular glaucoma

International Ophthalmology

Volumn 34, Issue 4, 2014, Pages 793-799

  Kang, Jung Youb ^a   Nam, Ki Yup ^a   Lee, Sang Joon ^a,b   Lee, Seung Uk ^a  

^a Kosin University   (South Korea)

^b University of Louisville School of Medicine   (United States)

Author keywords

Ahmed valve implantation; Bevacizumab; Neovascular glaucoma; Refractory glaucoma

Indexed keywords

ANTIGLAUCOMA AGENT; BEVACIZUMAB; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY;

ADULT; AGED; AHMED VALVE; ANTERIOR EYE CHAMBER DISEASE; ARTICLE; BLEB LEAK; CASE STUDY; CHOROID DETACHMENT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOPHTHALMITIS; EVISCERATION; FEMALE; FOLLOW UP; GLAUCOMA SURGERY; HUMAN; HYPHEMA; HYPOTONY MACULOPATHY; IMPLANT EXPOSURE; IMPLANTATION; INTERMETHOD COMPARISON; INTRAOCULAR HYPERTENSION; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; MALE; MEDICAL DEVICE COMPLICATION; MEDICAL RECORD REVIEW; NEOVASCULAR GLAUCOMA; OUTFLOW TRACT OBSTRUCTION; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT DURATION; VISUAL ACUITY; COMPARATIVE STUDY; GLAUCOMA DRAINAGE IMPLANT; GLAUCOMA, NEOVASCULAR; INTRAVITREAL DRUG ADMINISTRATION; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREOPERATIVE PERIOD;

ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; COMBINED MODALITY THERAPY; FEMALE; GLAUCOMA DRAINAGE IMPLANTS; GLAUCOMA, NEOVASCULAR; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PREOPERATIVE PERIOD; RETROSPECTIVE STUDIES; VISUAL ACUITY;

EID: 84904332240     PISSN: 01655701     EISSN: 15732630     Source Type: Journal    
DOI: 10.1007/s10792-013-9875-7     Document Type: Article

References (23)

1. Brown GC, Magargal LE, Schachat A, Shah H (1984) Neovascular glaucoma. Etiologic considerations. Ophthalmology 91:315-320
2. Funatsu H, Yamashita H, Sakata K et al (2005) Vitreous levels of vascular endothelial growth factors and intracellular adhesion molecule 1 are related to diabetic macular edema. Ophthalmology 112:908-916
3. Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335-2342 (Pubitemid 38702844)
4. Rosenfeld PJ, Fung AE, Puliafito CA (2005) Optical coherence tomography findings after intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 36:336-339 (Pubitemid 41073113)
5. Avery RL, Pieramici DJ, Rabena MD et al (2006) Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113:363-372
6. Beutel J, Peters S, Luke M et al (2010) Bevacizumab as adjuvant for neovascular glaucoma. Acta Ophthalmol 88:103-109
7. Sothornwit N (2008) Intravitreal bevacizumab for Ahmed glaucoma valve implantation in neovascular glaucoma: a case report. J Med Assoc Thai 91:162-165
8. Yazdani S, Hendi K, Pakaravan M et al (2007) Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma. J Glaucoma 16:437-439 (Pubitemid 47263045)
9. Yazdani S, Hendi K, Pakaravan M et al (2009) Intravitreal bevacizumab injection for neovascular glaucoma: a randomized controlled trial. J Glaucoma 18:632-637
10. Kahook MY, Schuman JS, Noecker RJ (2006) Intravitreal bevacizumab in a patient with neovascular glaucoma. Ophthalmic Surg Lasers Imaging 37:144-146
11. Moraczewski AL, Lee RK, Palmberg PF et al (2009) Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab. Br J Ophthalmol 93:589-593
12. Sidoti PA, Dunphy TR, Baerveldt G et al (1995) Experience with the Baeveldt glaucoma implant in treating neovascular glaucoma. Ophthalmology 102:1107-1118
13. Gheith ME, Siam GA, de Barros DS et al (2007) Role of intravitreal bevacizumab in neovascular glaucoma. J Ocul Pharmacol Ther 23:487-491 (Pubitemid 350202480)
14. Btioglu F, Astam N, Ozmert E (2008) Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma. Int Ophthalmol 28:59-61 (Pubitemid 351308686)
15. Vatavuk Z, Bencic G, Mandic Z (2007) Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion. Eur J Ophthalmol 17:269-271 (Pubitemid 46918117)
16. Takihara Y, Inatani M, Kawaji T et al (2011) Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma. J Glaucoma 20:196-201
17. MaKT,Yang JY,KimJHet al (2012) Surgical results ofAhmed valve implantationwith intraoperative bevacizumab injection in patients with neovascular glaucoma. J Glaucoma 21:331-336
18. Iliev ME, Dommig D, Wolf-Shnurrbursch U et al (2006) Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol 142:1054-1056 (Pubitemid 44853889)
19. Yoshida N, Hisatomi T, Ikeda Y et al (2011) Intravitreal bevacizumab treatment for neovascular glaucoma: histopathological analysis of trabeculectomy specimens. Graefes Arch Clin Exp Ophthalmol 249:1547-1552
20. Eid TM, Radwan A, el-Manawy W et al (2009) Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy. Can J Ophthalmol 44:451-456
21. Bakri SJ, Snyder MR, Reid JM et al (2007) Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology 114:855-859 (Pubitemid 46635858)
22. Silva Paula J, Jorge R, Alves Costa R et al (2006) Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma. Acta Ophthalmol Scand 84:5556-5557
23. Wakabayashi T, Oshima Y, Sakaguchi H et al (2008) Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology 115:1571-1580